- Pfizer Stock: Company Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. Barron’s
- Pfizer scraps daily weight loss pill after liver injury in one patient CNBC
- Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today Yahoo
- Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron Business Wire
- Pfizer will end development of daily weight-loss pill after liver injury Fox Business